Literature DB >> 19508835

Current concepts in malignant bowel obstruction management.

Eric Roeland1, Charles F von Gunten.   

Abstract

Malignant bowel obstruction (MBO) is a challenging complication of advanced cancer. Several pathophysiologic mechanisms are responsible for the syndrome, including mechanical compression, motility disorders, gastrointestinal secretion accumulation, decreased gastrointestinal absorption, and inflammation. The treatment of related symptoms requires a collaborative approach of surgical, interventional, and medical specialists. The surgical approach proves beneficial in selected patients with operable lesions, life expectancy greater than 2 months, and good performance status. Interventionalists place self-expanding metallic stents as a minimally invasive palliative method either as a definitive treatment or as a bridge to surgery. However, most patients with MBO are not candidates for surgery or stent placement. Medical management with opioids, antispasmodics, antiemetics, antisecretory agents, and corticosteroids is effective in controlling the symptoms associated with MBO. This article discusses the current understanding of MBO pathophysiology and emphasizes current MBO management concepts; it then reviews surgical, interventional, and medical approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508835     DOI: 10.1007/s11912-009-0042-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  36 in total

Review 1.  Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee.

Authors:  D J Feuer; K E Broadley; J H Shepherd; D P Barton
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

Review 2.  How to use octreotide for malignant bowel obstruction.

Authors:  Carla Ripamonti; Sebastiano Mercadante
Journal:  J Support Oncol       Date:  2004 Jul-Aug

3.  Premature closure of the Dutch Stent-in I study.

Authors:  J E van Hooft; P Fockens; A W Marinelli; P M Bossuyt; W A Bemelman
Journal:  Lancet       Date:  2006-11-04       Impact factor: 79.321

4.  Multivariate analysis of morbidity and mortality from the initial surgical management of obstructing carcinoma of the colon.

Authors:  I M Leitman; J D Sullivan; D Brams; J J DeCosse
Journal:  Surg Gynecol Obstet       Date:  1992-06

5.  Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies.

Authors:  M J Cunningham; C Bromberg; D C Kredentser; M B Collins; J H Malfetano
Journal:  Gynecol Oncol       Date:  1995-11       Impact factor: 5.482

6.  Quality of life in stoma patients.

Authors:  K P Nugent; P Daniels; B Stewart; R Patankar; C D Johnson
Journal:  Dis Colon Rectum       Date:  1999-12       Impact factor: 4.585

7.  Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis.

Authors:  G Mangili; G Aletti; L Frigerio; M Franchi; N Panacci; R Viganò; P DE Marzi; F Zanetto; A Ferrari
Journal:  Int J Gynecol Cancer       Date:  2005 Sep-Oct       Impact factor: 3.437

Review 8.  Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Authors:  D J Feuer; K E Broadley
Journal:  Cochrane Database Syst Rev       Date:  2000

9.  Management of bowel obstruction in advanced and terminal cancer patients.

Authors:  C Ripamonti; F De Conno; V Ventafridda; B Rossi; M J Baines
Journal:  Ann Oncol       Date:  1993-01       Impact factor: 32.976

10.  Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates.

Authors:  Cristina Martinez-Santos; Rosa F Lobato; José Manuel Fradejas; Isabel Pinto; Pablo Ortega-Deballón; Mariano Moreno-Azcoita
Journal:  Dis Colon Rectum       Date:  2002-03       Impact factor: 4.585

View more
  26 in total

Review 1.  Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications.

Authors:  Matthew Mobily; Jitesh A Patel
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

2.  Safety and efficacy of radiological percutaneous jejunostomy for decompression of malignant small bowel obstruction.

Authors:  Young-Joo Kim; Chang Jin Yoon; Nak Jong Seong; Sung-Gwon Kang; Seung-Won An; Young-Nam Woo
Journal:  Eur Radiol       Date:  2013-05-09       Impact factor: 5.315

3.  Percutaneous needle decompression in treatment of malignant small bowel obstruction.

Authors:  Ting-Hui Jiang; Xian-Jun Sun; Yue Chen; Hui-Qin Cheng; Shi-Ming Fang; Hao-Sheng Jiang; Yan Cao; Bing-Yan Liu; Shao-Qiu Wu; Ai-Wu Mao
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

4.  Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction.

Authors:  Anne Dittrich; Barbara Schubert; Michael Kramer; Felicitas Lenz; Karin Kast; Ulrich Schuler; Markus K Schuler
Journal:  Support Care Cancer       Date:  2017-04-22       Impact factor: 3.603

5.  Palliation of gastrointestinal obstruction.

Authors:  Golda Tradounsky
Journal:  Can Fam Physician       Date:  2012-06       Impact factor: 3.275

6.  Bowel obstruction in elderly ovarian cancer patients: a population-based study.

Authors:  Stephen J Mooney; Megan Winner; Dawn L Hershman; Jason D Wright; Daniel L Feingold; John D Allendorf; Alfred I Neugut
Journal:  Gynecol Oncol       Date:  2012-12-26       Impact factor: 5.482

7.  Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study.

Authors:  Megan Winner; Stephen J Mooney; Dawn L Hershman; Daniel L Feingold; John D Allendorf; Jason D Wright; Alfred I Neugut
Journal:  JAMA Surg       Date:  2013-08       Impact factor: 14.766

8.  Role of brain-derived neurotrophic factor in the pathogenesis of distention-associated abdominal pain in bowel obstruction.

Authors:  Y Fu; Y M Lin; J H Winston; R Radhakrishnan; L-Y M Huang; X Z Shi
Journal:  Neurogastroenterol Motil       Date:  2018-05-21       Impact factor: 3.598

9.  Tumor characteristics associated with malignant large bowel obstruction in stage IV colorectal cancer patients undergoing chemotherapy.

Authors:  Duk Hwan Kim; Bun Kim; Jae Hyuk Choi; Soo Jung Park; Sung Pil Hong; Jae Hee Cheon; Won Ho Kim; Tae Il Kim
Journal:  Int J Colorectal Dis       Date:  2016-09-09       Impact factor: 2.571

10.  Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital.

Authors:  Michael Hwang; Rosene Pirrello; Minya Pu; Karen Messer; Eric Roeland
Journal:  Support Care Cancer       Date:  2013-06-04       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.